Theravance Biopharma's blood pressure drug fails to meet main goal in late-stage trial
03/03/2026 13:35
March 3 (Reuters) - Theravance Biopharma TBPH.O said on Tuesday its experimental drug to treat a type of blood pressure disorder failed to meet the main goal in a late-stage study. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Krishna Chandra Eluri) ((Padmanabhan.Ananthan@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions